Connection

Raymund Razonable to Treatment Outcome

This is a "connection" page, showing publications Raymund Razonable has written about Treatment Outcome.
Connection Strength

0.114
  1. Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019. J Infect Dis. 2021 10 28; 224(8):1278-1286.
    View in: PubMed
    Score: 0.035
  2. Cytomegaloviraemia clearance with foscarnet during renal replacement therapy. J Antimicrob Chemother. 2018 02 01; 73(2):548-549.
    View in: PubMed
    Score: 0.027
  3. Epidemiology, risk factors, and outcomes of infections in patients undergoing liver transplantation for hilar cholangiocarcinoma. Clin Transplant. 2017 08; 31(8).
    View in: PubMed
    Score: 0.026
  4. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 11; 95(11):2382-2394.
    View in: PubMed
    Score: 0.008
  5. Traveler's Diarrhea Recommendations for Solid Organ Transplant Recipients and Donors. Transplantation. 2018 02; 102(2S Suppl 2):S35-S41.
    View in: PubMed
    Score: 0.007
  6. HHV-6 in liver transplantation: A literature review. Liver Int. 2018 02; 38(2):210-223.
    View in: PubMed
    Score: 0.007
  7. A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2013 Oct; 15(5):487-92.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.